Vaginal Infection External Quality Controls
Whole-workflow multi-analyte vaginal infection research use only (RUO) external quality controls are designed for molecular diagnostics, specifically for nucleic and amplification tests.
Setting the Gold Standard for Infectious Disease Diagnostic Standards
Ready-to-Use External Quality Controls
Microbix is the only supplier licensed to manufacture External Quality Swab Controls on Copan’s FLOQSwabs®. These swabs are room-temperature stable and have a wide storage range of 2-30°C.
Global Compliance
Manufactured under the strictest requirements of ISO 13485:2016, and Health Canada establishment licensed.
Unique Quality Control Solutions
Microbix offers inactivated multiplex Candida albicans/Candida glabrata/Candida krusei Positive Swabs that mimic patient specimen formats.

Download Our Full Product Brochure
Products
Product Name | REDx™ (IVD) Catalogue Number | PROCEEDx™ (RUO) Catalogue Number | Product Description |
Multi-Analyte Products | |||
Candida Panel Positive Swab | Coming soon | VP-S-102-M2 | Microbix Candida Panel Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Candida albicans, Candida glabrata, Candida krusei and human cells desiccated on a Copan FLOQSwab®. Microbix Candida Panel Positive Swab External Quality Controls have verified performance with Seegene Novaplex™ Candidiasis Assay, BD MAX™ Vaginal Panel Assay, Cepheid Xpert® Xpress MVP assay, and more. • Format: Copan FLOQSwab® • Storage Conditions: 2-30°C • Assay Compatibility: MDx
|
Bacterial Vaginosis Panel Positive Swab | Coming soon | VP-S-105-M1 | Microbix Bacterial Vaginosis Panel Positive Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with inactivated Gardnerella vaginalis, Atopobium vaginae, Lactobacillus crispatus, Lactobacillus jensenii, Megasphaera Type 1, Bacterial Vaginosis-Associated Bacterium 2 (BVAB2), Trichomonas vaginalis and human cells desiccated on a Copan FLOQSwab®. Microbix Bacterial Vaginosis Panel Positive Swab External Quality Controls have verified performance with Seegene Novaplex™ Bacterial Vaginosis plus Assay, BD MAX™ Vaginal Panel Assay, Cepheid Xpert® Xpress MVP assay, and more. • Format: Copan FLOQSwab® • Storage Conditions: 2-30°C • Assay Compatibility: MDx
|
Negative-Analyte Products | |||
NAAT Negative Swab (PROCEEDxTMFLOQ®️) | RED-S-99-M4 | VP-S-99-M4 | Microbix SARS-CoV-2 Negative Swab External Quality Controls are unassayed, whole-workflow samples that simulate clinical specimens. These products are formulated with human cells desiccated on a Copan FLOQSwab®.
|
Frequently Asked Questions
What vaginal infections are covered by your quality controls?
The Vaginal Infection Panel covers Candida albicans, Candida glabrata, Candida krusei Positive Swab, and the Bacterial Vaginosis panel products.
What are the storage requirements and shelf life for your vaginal infection external quality controls?
The shelf life of our Vaginal Infections Panel is 2 years from the manufacturing date when the swabs are stored at 2-30°C.
Can I request custom concentrations or formulations for the controls?
Please contact Customer Service for custom orders.
What should you use to elute the swab-based external quality controls?
The vaginal infection panel products can be eluted in 1-3mL of transport medium or a kit-specific elution buffer. Microbix sells 1mL and 3mL vials of Control Elution Buffer.

Testimonials
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.

We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs

We were looking for a set of controls that fully covered the range of high-risk HPV types and Microbix is the only company to have such a portfolio. After an extensive evaluation process, we concluded the performance of Microbix QAPs are exactly what Ulisse needs and the interactions with their team are delightful.
Bruna Marini, COO

MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)

r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics

We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality

Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.

We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
Your Dependable Source for Vaginal Infection External Quality Controls
Microbix provides specialized vaginal infection external quality controls on Copan’s FLOQSwab®, which are stable at room temperature, easy to use, and simulate patient specimen formats. These products are designed for nucleic acid amplification tests that detect the most common causes of vaginal infections, including bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. The vaginal infection panels are formulated with human cells, meeting molecular assay Sample Adequacy Control requirements.
The Vaginal Infection panel includes swab formulations of inactivated
- Candida albicans/Candida glabrata/Candida krusei Positive Swab
- Bacterial Vaginosis Panel Positive Swab
- NAAT Negative Swab

Speak to a Customer Service Representative
Let our knowledgeable experts help you secure your products today.
News & Insights from Our Diagnostics Experts

Microbix Reports Results for Q2 Fiscal 2025
Microbix reports results for its second quarter and first half of fiscal 2025 ended March 31, 2025 (“Q2” and “H1”). Sales for Q2 and H1 reflected differential growth between Antigens (up) and QAPs™ (...

Microbix & Aurevia Introduce Novel EQA Scheme
Microbix & Aurevia announce a pilot external quality assessment (“EQA”) program to help clinical laboratories establish their proficiency at using molecular diagnostic methods (e.g., PCR tests) to diagnose ...

Microbix Schedules Release of Results for Q2 Fiscal 2025
Microbix announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its second quarter of fiscal 2025 ended March 31, 2025 (“Q2 2025”) prior...